Cuu Long Pharmaceutical JSC (HOSE:DCL)

HOSE:DCL Balance Sheet

Financials in millions VND. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Jan 1, 2021
Cash & Equivalents	51,069	23,517	52,852	41,255	41,878
Short-Term Investments	428.3	257.8	14,000	446,623	877,876
Trading Asset Securities	104,795	94,795	94,795	70,270	-
Cash & Short-Term Investments	156,292	118,570	161,647	558,148	919,754
Cash Growth	31.81%	-26.65%	-71.04%	-39.31%	7.86%
Accounts Receivable	305,669	272,178	224,627	176,980	168,394
Other Receivables	384,812	431,418	444,704	134,123	41,393
Receivables	690,481	703,596	669,332	311,103	209,787
Inventory	345,751	365,031	315,080	308,196	226,988
Prepaid Expenses	3,371	2,522	1,709	1,660	3,741
Other Current Assets	236,114	213,406	274,478	82,048	81,948
Total Current Assets	1,432,009	1,403,124	1,422,245	1,261,155	1,442,218
Property, Plant & Equipment	949,575	834,368	649,459	491,030	325,499
Long-Term Investments	-	-	-	-	1,000
Other Intangible Assets	23,117	23,316	20,984	21,151	21,366
Long-Term Deferred Tax Assets	3,389	4,881	5,932	2,421	3,753
Other Long-Term Assets	16,056	11,770	6,703	5,271	6,570
Total Assets	2,424,146	2,277,460	2,105,323	1,781,028	1,800,407
Accounts Payable	105,264	66,129	36,751	31,117	26,721
Accrued Expenses	40,531	46,175	51,674	30,943	32,908
Short-Term Debt	394,064	349,732	288,008	361,270	240,662
Current Portion of Long-Term Debt	70,266	51,646	62,406	32,466	21,316
Current Portion of Leases	24,544	20,758	3,580	-	-
Current Income Taxes Payable	13,083	14,908	12,558	5,681	17,925
Current Unearned Revenue	-	-	-	-	730.92
Other Current Liabilities	7,233	68,726	99,090	249,752	3,318
Total Current Liabilities	654,984	618,075	554,068	711,229	343,581
Long-Term Debt	265,969	208,593	159,598	106,561	485,617
Other Long-Term Liabilities	-	-	-	-	213.9
Total Liabilities	920,953	826,668	713,666	817,790	829,411
Common Stock	730,410	730,410	730,410	588,328	568,328
Additional Paid-In Capital	220,359	220,359	220,359	7,236	-
Retained Earnings	533,388	481,561	422,844	316,282	301,709
Comprehensive Income & Other	20.17	20.17	20.17	20.17	31,486
Total Common Equity	1,484,177	1,432,350	1,373,633	911,866	901,522
Minority Interest	19,016	18,441	18,024	51,372	69,473
Shareholders' Equity	1,503,193	1,450,792	1,391,657	963,238	970,995
Total Liabilities & Equity	2,424,146	2,277,460	2,105,323	1,781,028	1,800,407
Total Debt	754,843	630,730	513,592	500,297	747,595
Net Cash (Debt)	-598,551	-512,160	-351,945	57,851	172,159
Net Cash Growth	-	-	-	-66.40%	52.61%
Net Cash Per Share	-8194.72	-7011.95	-5016.29	1006.12	3029.22
Filing Date Shares Outstanding	73.04	73.04	73.04	58.83	56.83
Total Common Shares Outstanding	73.04	73.04	73.04	58.83	56.83
Working Capital	777,026	785,049	868,177	549,927	1,098,637
Book Value Per Share	20319.77	19610.21	18806.32	15499.27	15862.71
Tangible Book Value	1,461,060	1,409,034	1,352,649	890,715	880,156
Tangible Book Value Per Share	20003.28	19291.00	18519.03	15139.76	15486.76
Buildings	230,984	181,452	181,452	184,154	120,901
Machinery	708,703	702,704	693,570	710,381	548,773
Construction In Progress	514,261	416,779	206,222	25,712	50,986

Updated Jan 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.